Clinical Program Leader

Summary

This role involves providing strategic medical guidance and leading the development of experimental oncology agents within the TCO portfolio, spanning from the preclinical development phase through clinical First in Human and Phase 1b/2 studies. The individual will be responsible for coordinating the planning, execution, and interpretation of early-phase oncology clinical trials.

About the Role

With a cohort of 6000 associates in the BioMedical Research division, Novartis stands at the forefront of innovation, focusing on transformative technologies aimed at delivering therapeutic breakthroughs for patients.

In the field of Translational Clinical Oncology, our global experts in disease, modality, and trial design are dedicated to the mission of advancing innovative therapies. This commitment is grounded in a profound understanding of cancer biology, pioneering study designs, evidence-based decision-making, and collaborations with the scientific and medical communities to expedite the availability of new medicines for patients.

Responsibilities

The selected candidate will:

• Act as a clinical leader for assigned global clinical programs, driving medical strategy implementation and operational deliverables for investigational products in a designated therapeutic area.
• Facilitate effective cross-functional communications to ensure alignment with global strategy and lead the development of clinical sections for trial and program-level regulatory documentation.
• Serve as a medical expert, engaging in interactions with external stakeholders (e.g., regulatory authorities, key opinion leaders, data monitoring committees, advisory boards) and internal Novartis stakeholders.
• Contribute to the medical and scientific training of relevant Novartis personnel and may serve as a speaker for such training events.
• Possess experience in leading early and/or late-phase oncology clinical programs within the pharma/biotech sector, combined with reputable experience from an academic medical center.
• Demonstrate a track record of significant contributions to the field, including the creation of new concepts and pursuit of innovative clinical discovery opportunities.

Role Requirements

The ideal candidate will bring the following qualifications:

• A medical degree, preferably with oncology board certification, along with a PhD in basic sciences or equivalent expertise.
• Clinical development experience in the pharma/biotech industry specializing in oncology.
• A minimum of three years of technical, operational, and managerial experience in the planning, execution, reporting, and design of clinical trials.
• Comprehensive knowledge of Good Clinical Practice, clinical trial design, statistics, regulatory processes, and the global clinical development process.
• A good understanding of oncology and prior experience in early clinical development is preferred.
• Strong communication, writing, and organizational skills, with fluency in both written and spoken English.

Why Novartis?

At Novartis, our purpose is to reimagine medicine to improve and extend people's lives. We strive to be the most valued and trusted medicines company globally, a goal achievable through the dedication of our people. Join us in this mission and help create a brighter future for patients.

Commitment to Diversity and Inclusion

Novartis is dedicated to fostering an outstanding, inclusive work environment with diverse teams that reflect the patients and communities we serve.

Accessibility & Accommodation

We are committed to providing reasonable accommodations to all individuals. Should you require assistance due to a medical condition or disability, please let us know about your needs.

Join Our Network

If this opportunity does not align with your experience or career goals, consider joining the Novartis Network to stay updated on future career opportunities.

Benefits and Rewards

Explore our Novartis Life Handbook for comprehensive information about the benefits and rewards we offer to support your well-being and professional growth.